You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hematologic Neoplasms

Showing 51 - 75 of 3,797
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mature B-cell Tumors Trial (Nemtabrutinib)

Not yet recruiting
  • Mature B-cell Neoplasms
  • (no location specified)
Jan 13, 2023

Hematologic Malignancies Trial in Shanghai (GNC-035)

Recruiting
  • Hematologic Malignancies
  • Guiyang, Guizhou, China
  • +3 more
Jan 13, 2023

Hematologic Malignancy, CAR-T Cell Therapy Trial in Boston (Educational Video Tool)

Active, not recruiting
  • Hematologic Malignancy
  • CAR-T Cell Therapy
  • Educational Video Tool
  • Boston, Massachusetts
    Massachusetts General Hospital
Jan 24, 2023

Hematologic Malignancy Trial in Milwaukee (Tacrolimus, Methotrexate, Tocilizumab)

Active, not recruiting
  • Hematologic Malignancy
  • Milwaukee, Wisconsin
    Froedtert Hospital
Jan 31, 2023

EBV-associated Haematologic Tumors Trial ((Autologous monocyte-derived DCs pulsed with allogeneic EBV-transformed

Not yet recruiting
  • EBV-associated Haematologic Neoplasms
  • (Autologous monocyte-derived DCs pulsed with allogeneic EBV-transformed B-lymphoblastoid cell line lysate
  • (no location specified)
Dec 4, 2022

Mechanisms of Disease R/R in CAR-T for Hematologic Malignancies

Recruiting
  • Hematologic Malignancy
  • Blood draw
  • Durham, North Carolina
    Duke University
Jun 22, 2022

Relapsed or Refractory Hematologic Malignancies Trial in Chicago (Omacetaxine, Venetoclax)

Recruiting
  • Relapsed or Refractory Hematologic Malignancies
  • Chicago, Illinois
    University of Illinois Cancer Center
Sep 27, 2022

Hematologic Diseases, Hematologic Malignancy, Acute Lymphoblastic Leukemia Trial in Miami (device, procedure, drug)

Withdrawn
  • Hematologic Diseases
  • +5 more
  • CliniMACS
  • +7 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Sep 26, 2022

Adult Relapsed/Refractory B-cell Hematologic Malignancies Trial in Beijing (CD19-CAR-NK)

Recruiting
  • Adult Relapsed/Refractory B-cell Hematologic Malignancies
  • CD19-CAR-NK
  • Beijing, Beijing, China
    The Fifth Medical Center of Chinese People's Liberation Army (PL
Dec 1, 2022

Hematologic Tumors, Solid Tumor Trial in Madison (PMMTB (Precision Medicine Molecular Tumor Board))

Recruiting
  • Hematologic Neoplasms
  • Solid Neoplasm
  • PMMTB (Precision Medicine Molecular Tumor Board)
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Jul 7, 2022

Immunity to Infection in Healthy Participants and Cancer

Recruiting
  • Influenza
  • +3 more
  • Biological sample collection
  • Tuebingen, Baden-Wuerttemberg, Germany
    University Hopsital Tuebingen
Mar 31, 2023

Hematologic Malignancies Trial in La Jolla (Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant)

Suspended
  • Hematologic Malignancies
  • Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant
  • La Jolla, California
    UCSD Medical Center
Jul 20, 2022

Hematologic Malignancies Trial in Minneapolis (Haplo HCT <55 years old, Haplo HCT =55 years old, GVHD Prophylaxis)

Recruiting
  • Hematologic Malignancies
  • Haplo HCT <55 years old
  • +4 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Jan 25, 2023

B-Cell Lymphoblastic Leukemia/Lymphoma Trial in Kunming (Anti-CD19 UCAR-NK cells)

Recruiting
  • B-Cell Lymphoblastic Leukemia/Lymphoma
  • Anti-CD19 UCAR-NK cells
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force of People's Libe
Dec 19, 2022

Prospective Procurement of Tumor Tissue to Identify Novel

Enrolling by invitation
  • Solid Tumors
  • +7 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Pediatric Patients, Hematologic Malignancy, Other Hematologic Condition Trial in Aurora (CliniMACS Plus Instrument)

    Not yet recruiting
    • Pediatric Patients
    • +2 more
    • CliniMACS Plus Instrument
    • Aurora, Colorado
      Children's Hospital Colorado
    Jun 29, 2022

    Hematological Malignancies Trial (Anti-CD7 CAR-T)

    Not yet recruiting
    • Hematological Malignancies
    • Anti-CD7 CAR-T
    • (no location specified)
    Jul 8, 2022

    B-cell Lymphoma, B-cell Leukemia Trial in Kunming (anti-CD19 UCAR-NK cells)

    Withdrawn
    • B-cell Lymphoma
    • B-cell Leukemia
    • anti-CD19 UCAR-NK cells
    • Kunming, Yunnan, China
      Kunming Hope of Health Hospital
    Nov 27, 2022

    Acute GVHD, Hematopoietic and Lymphoid System Tumor Trial in Duarte (Cholestyramine, Leflunomide, Steroid Therapy)

    Recruiting
    • Acute Graft Versus Host Disease
    • Hematopoietic and Lymphoid System Neoplasm
    • Duarte, California
      City of Hope Medical Center
    Jan 5, 2023

    Graft Vs Host Disease, Graft-versus-host-disease, Acute Myeloid Leukemia Trial (CliniMACS® device)

    Not yet recruiting
    • Graft Vs Host Disease
    • +5 more
    • CliniMACS® device
    • (no location specified)
    Jul 20, 2023

    Hematologic Malignancies Trial in Australia, United States (APG-2575)

    Recruiting
    • Hematologic Malignancies
    • Jacksonville, Florida
    • +4 more
    Aug 12, 2022

    Acute Leukemia, Multiple Myeloma, Non-Hodgkin Lymphoma Trial (3D189)

    Recruiting
    • Acute Leukemia
    • +3 more
    • 3D189
    • Guangzhou, Guangdong, China
    • +3 more
    Jan 2, 2023

    CB-Long-Term Safety Study (CB-LTSS)

    Enrolling by invitation
    • Lymphoma, Non-Hodgkin
    • +7 more
    • Allogeneic CAR-T therapy
    • Irvine, California
    • +3 more
    Nov 18, 2022

    Cognitive Aftereffects of Neurotoxicity in Children and Young

    Not yet recruiting
    • Lymphoma
    • Leukemia
      • Los Angeles, California
      • +2 more
      Feb 2, 2023

      Chronic Graft-versus-Host-Disease, Allogeneic Hematopoietic Stem Cell Transplantation, Leukemia Trial

      Not yet recruiting
      • Chronic Graft-versus-Host-Disease
      • +4 more
        • (no location specified)
        Jan 11, 2023